DOCSLIB.ORG

Advertising (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Advertising (PDF) FROM SANTA CRUZ BIOTECHNOLOGY, INC. siRNA GENE SILENCERS AND IMMUNODETECTION REAGENTS Tumor Suppressors/Apoptosis Kinases and Phosphatases Neurobiology Cell Cycle Proteins Growth Factors and Hormones Channel Proteins Transcription Regulators Membrane Receptors Lymphocyte Signaling Homeodomain Proteins Signaling Intermediates Cell Adhesion Proteins Steroid Receptors GDP/GTP Binding Proteins Structural Proteins WWW. SCBT. COM HEADQUARTERS EUROPEAN SUPPORT OFFICE Santa Cruz Biotechnology, Inc. Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Bergheimer Str. 89-2 Santa Cruz, California 95060 69115 Heidelberg, Germany Tel. 831.457.3800 Tel. +49 6221 4503 0 Toll Free: 800.457.3801 Toll Free: +00800 4573 8000 Now introducing THP IL-17, IL-23, TGF-β1 ELISA, ELISPOT & Flow Cytometry TGF-β + IL-6 (differentiation) IL-23 (survival, expansion) IL-17 secretion TH-17 Discover the panel of validated cytokine reagents from eBioscience • Recombinant proteins (lowest endotoxin in the industry, 10000 Standard Data tagless, authentic, non-linked, carrier-free, bulk & small sizes) log(y) = 0.917log(x) − 2.62 0 β 10 TGF- 1, IL-17A, IL-17F, IL-23, IL-27 1000 488 ® • ELISA (matched pairs, sets, kits with pre-coated plates) −1 10 TGF-β1, IL-15, IL-17A, IL-23, IL-29/IFN-λ 100 Log Scale of OD • Neutralization (Functional Grade antibodies are sterility & 10 1 2 3 10 10 10 IL-17 - Alexa Fluor Log Scale of [IL-23] (pg/ml) endotoxin tested; lowest endotoxin in the industry) 1 Human IL-23 (p19/p40) ELISA: Standard IL-17A, IL-23 p19 1 10 100 1000 10000 CD4 - APC curve for Human IL-23 (p19/p40) ELISA set with no cross-reactivity with p40 • ELISPOT (stand alone antibody pairs and sets) Human IL-17 IC Flow: Human PBMCs monomer or IL-12 p70, and an assay were stimulated with TPA/ionomycin in sensitivity below 15pg/ml. Granzyme B, IL-13, IL-15, IL-17A, IL-29/IFN-λ the presence of monensin for 5 hours. • Intracellular staining for flow cytometric analysis (FITC, PE, PE-Cy5, APC, Alexa Fluor® conjugates, Pacific Blue®) Granzyme B, IL-13, IL-17A, IL-1β, T-bet, IFN-α2 eBioscience carries over 6,000 premium-quality novel and staple reagents. For more information, visit www.ebioscience.com. Use code JI-FEB7 to receive a free t-shirt with your next purchase.* Human IL-17 ELISPOT: Human PBMCs * Expires 3/31/07. One offer per lab. For end users only. activated with PMA/ionomycin for 24 Alexa Fluor® and Pacific Blue® are registered trademarks of and licensed under patents assigned to Molecular Probes, Inc. for research use only. hours. www.ebioscience.com 888.999.1371 858.642.2046 888.810.6168 [email protected] [email protected] Human CD3 PE Mouse CD3 PE Human CD4 APC 1 2 Human FOXP3 Alexa Fluor® 488 Human IL-2 Alexa Fluor® 647 Mouse CD19 PE/Cy7 BioLegend offers most comprehensive panel of fluorochrome conjugated antibodies for flow cytometry and microscopy in the formats of FITC, PE, PE/Cy5, PE/Cy5.5, PE/Cy7, APC, APC/Cy5.5, APC/Cy7, Alexa Fluor®® 488, Alexa Fluor 647, Alexa Fluor® 700, Pacific Blue™ LESS NVESTM NT. M RE PA OFF. Invitrogen antibodies are guaranteed to work. With Invitrogen as your antibody center of excellence, you can get what you’re looking for, no matter the application. Immunoprecipitation. Immunohistochemistry. Western blots. Immunofluorescence. Flow cytometry. Cell separation. ELISA. Finding the antibody you need is easier than ever with our antibody selector tool. Just select your target protein, then filter by application, conjugate, or species, or use advanced search features to get exactly what you need when you need it. Start getting results at www.invitrogen.com/antibodies. 2006 © Invitrogen Corporation. All rights reserved. These products may be covered by one or more Limited Use Label Licenses (see the Invitrogen catalog or our website, www.invitrogen.com). A New Adjuvant from Avanti® The combination of dimethyl dioctadecyl ammonium bromide and the synthetic cord factor trehalose dibehenate promotes strong protective immune responses, without overt toxic- ity, against M. tuberculosis infection in a vaccination model and thus appears to be a very promising candidate for the development of human vaccines.* D-(+)-trehalose 6,6’-dibehenate (TDB) Avanti Number 890808 Made with Avanti’s signature >99% purity. Also available produced under cGMP guidelines. *Holten-Andersen, L., T.M. Doherty, K.S. Korsholm, and P. Andersen. (2004). Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect Immun 72:1608-17. Phone 800-227-0651 (205-663-2494 International) or Email [email protected] for details of Avanti’s selection of lipids of unparalleled purity visit www.avantilipids.com FROM RESEARCH TO CGMP PRODUCTION - AVANTI’S HERE FOR YOU Notice to Authors Submitting Manuscripts to The Journal of Immunology “Rapid Inspector” Tool is Integral Component of The JI’s Electronic Manuscript Submission Process As of October 1, 2004, The Journal of Immunology (The JI) began accepting new manuscript submissions exclusively via online submission, using eMTS, The JI’s manuscript submission and tracking system. Authors of revised and accepted manuscripts must test the quality of their digital images using the preflight software Rapid Inspector. This step is a requirement of The JI’s all-electronic production process. Preflight software is available as a downloadable Java applet by visiting: http://rapidinspector.cadmus.com/zim. The above-referenced website includes detailed instructions on the installation of this application as well as guidelines for solving common problems with digital images. For assistance in using this tool, or in resolving problems that are reported with your images, contact The JI’s digital art support team. This is a dedicated helpline for The JI’s authors from which you can expect a response within 24 hours. It is available through e-mail and telephone: E-mail: [email protected] Telephone: 410-691-6211 The helpdesk will guide you through solving your problems with digital art and support you in preparing images for publication. BD™ Cytometric Bead Array Flex Set Bead-Based Immunoassays Easy to multiplex. Easy to love. Stop doing time-consuming ELISA and Our simple protocol requires minimal western blot assays and save valuable hands-on time, leaving you to samples using BD™ CBA Flex Set concentrate on what really matters: bead-based immunoassays for your results. measurement of cytokines and cell signaling proteins. Measure multiple Visit us at bdbiosciences.com/flexset proteins simultaneously with our easy- to learn more. to-use system, including pre-optimized Human cytokine 30-plex acquired on assays, buffers, and setup reagents. the BD FACSArray bioanalyzer BD Biosciences 2350 Qume Drive This product is for Research Use Only. Not for use in diagnostic or therapeutic procedures. San Jose, CA 95131 BD, BD Logo and all other trademarks are the property of Becton, Dickinson and Company. ©2007 BD. bdbiosciences.com 06-810038-9 ® ® cell sciences www.CytokineCenter.com IL-16 (121 a.a.) PF-4 IL-16 (130 a.a.) PIGF-1 IL-17 PIGF-2 IL-17B PKA D-subunit Cytokine Center IL-17D PKC-D IL-17E PKC-J Browse our web site with over 1300 IL-17F Pleiotrophin proteins, including recombinant IL-19 PLGF-1 IL-20 Polymyxin B (PMB) cytokines, growth factors, chemokines IL-21 PRAS40 and neurotrophins. Daily shipping and IL-22 PRL-1 IL-31 PRL-2 competitive pricing are offered. Bulk Insulin PRL-3 quantities of many proteins available. IP-10 Prokineticin-2 JE Prolactin Cell Sciences also carries corresponding JNK2a1 Protirelin antibodies and cytokine ELISA kits. JNK2a2 PTHrP KC / CXCL1 PTP1B PROTEINS CD40 Ligand / TRAP G-CSF KGF PTP-IA2 4-1BBL CD95 / sFas Ligand D-Galactosidase A L-asparaginase PTP-MEG2 4-1BB Receptor CD105 / Endoglin Galectin-1 LAG-1 PTP-PEST 6 Ckine CHIPS Galectin-3 LALF Peptide sRANK ACAD8 CNTF Gastrointestinal CA LAR-PTP sRANKL ACAT2 Collagen GCP-2 LBP RANTES gAcrp30/Adipolean CREB GDF-3 LC-1 RELM-D Activin A CTACK / CCL27 GDF-9 LD-78E RELM-E Activin B CTGF GDF-11 LDH Resistin ACY1 CTGFL / WISP-2 GDNF LEC / NCC-4 RPTPE ADAT1 CTLA-4 / Fc GLP-1 Leptin RPTPJ Adiponectin CXCL16 Glucagon LIGHT RPTPP ADRP CYR61 GM-CSF LIX SCF AITRL Cytokeratin 8 Goserelin LKM SCGF-D Akt1 DEP-1 GPBB LL-37 SCGF-E Alpha-Feto Protein (AFP) Desmopressin Granzyme B Lungkine / CXCL15 SDF-1D Alpha-Galactosidase A Disulfide Oxidoreductase GROD Lymphotactin SDF-1E Angiopoietin-1 (Ang-1) E-selectin GROE sLYVE-1 Secretin Angiopoietin-2 (Ang-2) ECGF GROJ M-CSF SF20 Angiostatin K1-3 EGF GRO/MGSA MCP-1 (MCAF) SHP-2 Annexin-V Elafin / SKALP Growth Hormone MCP-2 STAT1 apo-SAA EMAP-II Growth Hormone BP MCP-3 c-Src Apoliprotein A-1 ENA-78 / CXCL5 GST-p21/WAF-1 MCP-4 TACI Apoliprotein E2 Endostatin HB-EGF MCP-5 TARC Apoliprotein E3 Enteropeptidase HCC-1 MDC (67 a.a.) TC-PTP Apoliprotein E4 Eotaxin / CCL11 HGF MDC (69 a.a.) TECK APRIL Eotaxin-2 Histdyl-tRNA synthetase MDH TFF2 Artemin Eotaxin-3 (TSC) Histrelin MEC TGF-D ATF2 Epigen HRG1-E1 Mek-1 TGF-E1 Aurora A Epiregulin I-309 MIA TGF-E2 Aurora B EPHB2 I-TAC Midkine TGF-E3 BAFF EPHB4 IFN-D MIG / CXCL9 Thymosin D1 BAFF Receptor Eptifbatide IFN-D A MIP-1D/ CCL3 sTIE-1/Fc Chimera BCA-1 / BLC / CXCL13 Erk-2 IFN-D 2a MIP-1E/ CCL4 sTIE-2/Fc Chimera BCMA Erythropoietin (EPO) IFN-D 2b MIP-3 / CCL23 TL-1A BD-1 Exodus-2 IFN-E MIP-3D/ CCL20 TNF-D BD-2 Fas Ligand IFN-J MIP-3E/ CCL19 TNF-E BD-3 Fas Receptor IFN-Omega MIP-4 (PARC) / CCL18 sTNF-receptor Type I BDNF FGF-1 (acidic) IGF-I MIP-5 / CCL15 sTNF-receptor Type
Load more

Recommended publications
  • Increased Expression of Epidermal Growth Factor Receptor and Betacellulin During the Early Stage of Gastric Ulcer Healing
    505-510 11/6/08 12:55 Page 505 MOLECULAR MEDICINE REPORTS 1: 505-510, 2008 505 Increased expression of epidermal growth factor receptor and betacellulin during the early stage of gastric ulcer healing GEUN HAE CHOI, HO SUNG PARK, KYUNG RYOUL KIM, HA NA CHOI, KYU YUN JANG, MYOUNG JA CHUNG, MYOUNG JAE KANG, DONG GEUN LEE and WOO SUNG MOON Department of Pathology, Institute for Medical Sciences, Chonbuk National University Medical School and the Center for Healthcare Technology Development, Jeonju, Korea Received January 2, 2008; Accepted February 22, 2008 Abstract. Epidermal growth factor receptor (EGFR) is from tissue necrosis triggered by mucosal ischemia, free important for the proliferation and differentiation of gastric radical formation and the cessation of nutrient delivery, which mucosal cells. Betacellulin (BTC) is a novel ligand for EGFR are caused by vascular and microvascular injury such as Since their role is unclear in the ulcer healing process, we thrombi, constriction or other occlusions (2). Tissue necrosis investigated their expression. Gastric ulcers in 30 Sprague- and the release of leukotriene B attract leukocytes and Dawley rats were induced by acetic acid. RT-PCR and macrophages, which release pro-inflammatory cytokines Western blotting were performed to detect EGFR and BTC. (e.g. TNFα, IL-1α, and IL-1ß). These in turn activate local Immunohistochemical studies were performed to detect fibroblasts, endothelial and epithelial cells. Histologically, an EGFR, BTC and proliferating cell nuclear antigen (PCNA). ulcer has two characteristic structures: a distinct ulcer margin The expression of EGFR and the BTC gene was significantly formed by the adjacent non-necrotic mucosa, and granulation increased at 12 h, 24 h and 3 days after ulcer induction tissue composed of fibroblasts, macrophages and proliferating (P<0.05).
    [Show full text]
  • Cellular and Plasma Proteomic Determinants of COVID-19 and Non-COVID-19 Pulmonary Diseases Relative to Healthy Aging
    RESOURCE https://doi.org/10.1038/s43587-021-00067-x Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging Laura Arthur1,8, Ekaterina Esaulova 1,8, Denis A. Mogilenko 1, Petr Tsurinov1,2, Samantha Burdess1, Anwesha Laha1, Rachel Presti 3, Brian Goetz4, Mark A. Watson1, Charles W. Goss5, Christina A. Gurnett6, Philip A. Mudd 7, Courtney Beers4, Jane A. O’Halloran3 and Maxim N. Artyomov1 ✉ We examine the cellular and soluble determinants of coronavirus disease 2019 (COVID-19) relative to aging by performing mass cytometry in parallel with clinical blood testing and plasma proteomic profiling of ~4,700 proteins from 71 individuals with pul- monary disease and 148 healthy donors (25–80 years old). Distinct cell populations were associated with age (GZMK+CD8+ T cells and CD25low CD4+ T cells) and with COVID-19 (TBET−EOMES− CD4+ T cells, HLA-DR+CD38+ CD8+ T cells and CD27+CD38+ B cells). A unique population of TBET+EOMES+ CD4+ T cells was associated with individuals with COVID-19 who experienced moderate, rather than severe or lethal, disease. Disease severity correlated with blood creatinine and urea nitrogen levels. Proteomics revealed a major impact of age on the disease-associated plasma signatures and highlighted the divergent contri- bution of hepatocyte and muscle secretomes to COVID-19 plasma proteins. Aging plasma was enriched in matrisome proteins and heart/aorta smooth muscle cell-specific proteins. These findings reveal age-specific and disease-specific changes associ- ated with COVID-19, and potential soluble mediators of the physiological impact of COVID-19.
    [Show full text]
  • Anti-OX40 Antibody Directly Enhances the Function of Tumor-Reactive CD8+ T Cells
    Author Manuscript Published OnlineFirst on August 1, 2019; DOI: 10.1158/1078-0432.CCR-19-1259 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Anti-OX40 antibody directly enhances the function of tumor-reactive CD8+ T cells and synergizes with PI3Kβ inhibition in PTEN loss melanoma Weiyi Peng1,5*, Leila J. Williams1, Chunyu Xu1,5, Brenda Melendez1, Jodi A. McKenzie1,6, Yuan Chen1, Heather Jackson2, Kui S. Voo3, Rina M. Mbofung1,7,, Sara E. Leahey1, Jian Wang4, Greg Lizee1, Hussein A. Tawbi1, Michael A. Davies1, Axel Hoos2, James Smothers2, Roopa Srinivasan2, Elaine Paul2, Niranjan Yanamandra2* and Patrick Hwu1* 1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. 2Oncology R&D, Immuno-Oncology and Combinations RU, GlaxoSmithKline, 1250 S. Collegeville Rd, Collegeville, PA 19426, United States 3Oncology Research for Biologics and Immunotherapy Translation Platform, The University of Texas MD Anderson Cancer Center, Houston, TX. 4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. 5Present address: Department of Biology and Biochemistry, University of Houston, Houston, TX. 6Present address: Eisai Inc., Woodcliff Lake, NJ. 7Present address: Merck Research Laboratories, Palo Alto, CA. Running Title: OX40 agonist-based cancer immunotherapy Keywords: OX40, PI3K, cancer immunotherapy Downloaded from clincancerres.aacrjournals.org on September 25, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 1, 2019; DOI: 10.1158/1078-0432.CCR-19-1259 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 2 *Corresponding Authors: Patrick Hwu, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
    [Show full text]
  • Recombinant Human Betacellulin Promotes the Neogenesis of -Cells
    Recombinant Human Betacellulin Promotes the Neogenesis of ␤-Cells and Ameliorates Glucose Intolerance in Mice With Diabetes Induced by Selective Alloxan Perfusion Koji Yamamoto, Jun-ichiro Miyagawa, Masako Waguri, Reiko Sasada, Koichi Igarashi, Ming Li, Takao Nammo, Makoto Moriwaki, Akihisa Imagawa, Kazuya Yamagata, Hiromu Nakajima, Mitsuyoshi Namba, Yoshihiro Tochino, Toshiaki Hanafusa, and Yuji Matsuzawa Betacellulin (BTC), a member of the epidermal growth factor family, is expressed predominantly in the human pancreas and induces the differentiation of a pancreatic ancreatic ␤-cells are thought to be terminally dif- acinar cell line (AR42J) into insulin-secreting cells, ferentiated cells with little ability to regenerate. suggesting that BTC has a physiologically important However, proliferation of preexisting ␤-cells and role in the endocrine pancreas. In this study, we exam- differentiation of ␤-cells from precursor cells, ined the in vivo effect of recombinant human BTC P (rhBTC) on glucose intolerance and pancreatic mor- mainly residing in the pancreatic duct lining, have been phology using a new mouse model with glucose intoler- demonstrated in some animal models (1–5). Recently, we ance induced by selective alloxan perfusion. RhBTC developed a new mouse model of diabetes induced by selec- (1 µg/g body wt) or saline was injected subcutaneously tive perfusion of alloxan (100 µg/g body wt) during the every day from the day after alloxan treatment. The clamping of the superior mesenteric artery (1). In this model, intraperitoneal glucose tolerance test revealed no dif- glucose intolerance spontaneously resolves after one year ference between rhBTC-treated and rhBTC-untreated because of the proliferation of surviving ␤-cells in the non- glucose-intolerant mice at 2–4 weeks.
    [Show full text]
  • Serum Protein Fingerprinting by PEA Immunoassay Coupled with a Pattern-Recognition Algorithms Distinguishes MGUS and Multiple Myeloma
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 41), pp: 69408-69421 Research Paper Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma Petra Schneiderova1,*, Tomas Pika2,*, Petr Gajdos3, Regina Fillerova1, Pavel Kromer3, Milos Kudelka3, Jiri Minarik2, Tomas Papajik2, Vlastimil Scudla2 and Eva Kriegova1 1Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic 2Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic 3Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic *These authors have contributed equally to this work Correspondence to: Eva Kriegova, email: [email protected] Keywords: serum pattern, cytokines, growth factors, proximity extension immunoassay, post-transplant serum pattern Received: May 04, 2016 Accepted: July 28, 2016 Published: August 12, 2016 Copyright: Schneiderova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Serum protein fingerprints associated with MGUS and MM and their changes in MM after autologous stem cell transplantation (MM-ASCT, day 100) remain unexplored. Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS.
    [Show full text]
  • Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Neutrophil chemoattractant receptors in health and disease: double-edged swords Mieke Metzemaekers1, Mieke Gouwy1 and Paul Proost 1 Neutrophils are frontline cells of the innate immune system. These effector leukocytes are equipped with intriguing antimicrobial machinery and consequently display high cytotoxic potential. Accurate neutrophil recruitment is essential to combat microbes and to restore homeostasis, for inflammation modulation and resolution, wound healing and tissue repair. After fulfilling the appropriate effector functions, however, dampening neutrophil activation and infiltration is crucial to prevent damage to the host. In humans, chemoattractant molecules can be categorized into four biochemical families, i.e., chemotactic lipids, formyl peptides, complement anaphylatoxins and chemokines. They are critically involved in the tight regulation of neutrophil bone marrow storage and egress and in spatial and temporal neutrophil trafficking between organs. Chemoattractants function by activating dedicated heptahelical G protein-coupled receptors (GPCRs). In addition, emerging evidence suggests an important role for atypical chemoattractant receptors (ACKRs) that do not couple to G proteins in fine-tuning neutrophil migratory and functional responses. The expression levels of chemoattractant receptors are dependent on the level of neutrophil maturation and state of activation, with a pivotal modulatory role for the (inflammatory) environment. Here, we provide an overview
    [Show full text]
  • Human B-Cell Proliferation and Intracellular Signaling: Part 3
    1872 Diabetes Volume 64, June 2015 Andrew F. Stewart,1 Mehboob A. Hussain,2 Adolfo García-Ocaña,1 Rupangi C. Vasavada,1 Anil Bhushan,3 Ernesto Bernal-Mizrachi,4 and Rohit N. Kulkarni5 Human b-Cell Proliferation and Intracellular Signaling: Part 3 Diabetes 2015;64:1872–1885 | DOI: 10.2337/db14-1843 This is the third in a series of Perspectives on intracel- signaling pathways in rodent and human b-cells, with lular signaling pathways coupled to proliferation in pan- a specific focus on the links between b-cell proliferation creatic b-cells. We contrast the large knowledge base in and intracellular signaling pathways (1,2). We highlight rodent b-cells with the more limited human database. what is known in rodent b-cells and compare and contrast With the increasing incidence of type 1 diabetes and that to the current knowledge base in human b-cells. In- the recognition that type 2 diabetes is also due in part variably, the human b-cell section is very brief compared fi b to a de ciency of functioning -cells, there is great ur- with the rodent counterpart, reflecting the still primitive gency to identify therapeutic approaches to expand hu- state of our understanding of mitogenic signaling in hu- b man -cell numbers. Therapeutic approaches might man b-cells. To emphasize this difference, each figure is include stem cell differentiation, transdifferentiation, or divided into two panels, one summarizing rodent b-cell expansion of cadaver islets or residual endogenous signaling and one for human b-cells. Our intended audi- b-cells. In these Perspectives, we focus on b-cell ence includes trainees in b-cell regeneration as well as proliferation.
    [Show full text]
  • The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
    International Journal of Molecular Sciences Review The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature Jan Korbecki 1 , Klaudyna Kojder 2, Patrycja Kapczuk 1, Patrycja Kupnicka 1 , Barbara Gawro ´nska-Szklarz 3 , Izabela Gutowska 4 , Dariusz Chlubek 1 and Irena Baranowska-Bosiacka 1,* 1 Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] (J.K.); [email protected] (P.K.); [email protected] (P.K.); [email protected] (D.C.) 2 Department of Anaesthesiology and Intensive Care, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-281 Szczecin, Poland; [email protected] 3 Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] 4 Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wlkp. 72 Av., 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-914661515 Abstract: Hypoxia is an integral component of the tumor microenvironment. Either as chronic or cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible factor-1 (HIF-1) and nuclear factor (NF-κB), with cycling hypoxia showing a stronger proinflammatory influ- ence. One of the systems affected by hypoxia is the CXC chemokine system. This paper reviews all available information on hypoxia-induced changes in the expression of all CXC chemokines (CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, CXCL12 Citation: Korbecki, J.; Kojder, K.; Kapczuk, P.; Kupnicka, P.; (SDF-1), CXCL13, CXCL14, CXCL15, CXCL16, CXCL17) as well as CXC chemokine receptors— Gawro´nska-Szklarz,B.; Gutowska, I.; CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CXCR7 and CXCR8.
    [Show full text]
  • Follicular Thyroid Carcinoma but Not Adenoma Recruits Tumor-Associated
    Huang et al. BMC Cancer (2016) 16:98 DOI 10.1186/s12885-016-2114-7 RESEARCH ARTICLE Open Access Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15 Feng-Jiao Huang1†, Xiao-Yi Zhou1†, Lei Ye1*, Xiao-Chun Fei2, Shu Wang1,3, Weiqing Wang1 and Guang Ning1,3 Abstract Background: The differential diagnosis of follicular thyroid carcinoma (FTC) and follicular adenoma (FA) before surgery is a clinical challenge. Many efforts have been made but most focusing on tumor cells, while the roles of tumor associated macrophages (TAMs) remained unclear in FTC. Here we analyzed the differences between TAMs in FTC and those in FA. Methods: We first analyzed the density of TAMs by CD68 immunostaining in 59 histologically confirmed FTCs and 47 FAs. Cytokines produced by FTC and FA were profiled using antibody array, and validated by quantitative PCR. Chemotaxis of monocyte THP-1 was induced by condition medium of FTC cell lines (FTC133 and WRO82-1) with and without anti-CCL15 neutralizing antibody. Finally, we analyzed CCL15 protein level in FTC and FA by immunohistochemistry. Results: The average density of CD68+ cells was 9.5 ± 5.4/field in FTC, significantly higher than that in FA (4.9 ± 3.4/field, p < 0.001). Subsequently profiling showed that CCL15 was the most abundant chemokine in FTC compared with FA. CCL15 mRNA in FTC was 51.4-folds of that in FA. CM of FTC cell lines induced THP-1 cell chemotaxis by 33 ~ 77 %, and anti-CCL15 neutralizing antibody reduced THP-1 cell migration in a dose-dependent manner.
    [Show full text]
  • Mouse CXCL15 ELISA Kit (ARG82062)
    Product datasheet [email protected] ARG82062 Package: 96 wells Mouse CXCL15 ELISA Kit Store at: 4°C Summary Product Description Mouse CXCL15 ELISA Kit is an Enzyme Immunoassay kit for the quantification of Mouse CXCL15 in serum, plasma and cell culture supernatants. Tested Reactivity Ms Tested Application ELISA Target Name CXCL15 Conjugation HRP Conjugation Note Substrate: TMB and read at 450 nm. Sensitivity 62.5 pg/ml Sample Type Serum, plasma and cell culture supernatants. Standard Range 125 - 8000 pg/ml Sample Volume 100 µl Alternate Names Scyb15; weche; Small-inducible cytokine B15; C-X-C motif chemokine 15; Lungkine; lungkine Application Instructions Assay Time 4.5 hours Properties Form 96 well Storage instruction Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol Cxcl15 Gene Full Name chemokine (C-X-C motif) ligand 15 Function Chemotactic for neutrophils. Involved in lung-specific neutrophil trafficking during normal and inflammatory conditions. [UniProt] Highlight Related products: CXCL antibodies; CXCL ELISA Kits; CXCL Duos / Panels; CXCL recombinant proteins; New ELISA data calculation tool: Simplify the ELISA analysis by GainData www.arigobio.com 1/2 Images ARG82062 Mouse CXCL15 ELISA Kit standard curve image ARG82062 Mouse CXCL15 ELISA Kit results of a typical standard run with optical density reading at 450 nm. www.arigobio.com 2/2 Powered by TCPDF (www.tcpdf.org).
    [Show full text]
  • The Chemokine System in Innate Immunity
    Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press The Chemokine System in Innate Immunity Caroline L. Sokol and Andrew D. Luster Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 Correspondence: [email protected] Chemokines are chemotactic cytokines that control the migration and positioning of immune cells in tissues and are critical for the function of the innate immune system. Chemokines control the release of innate immune cells from the bone marrow during homeostasis as well as in response to infection and inflammation. Theyalso recruit innate immune effectors out of the circulation and into the tissue where, in collaboration with other chemoattractants, they guide these cells to the very sites of tissue injury. Chemokine function is also critical for the positioning of innate immune sentinels in peripheral tissue and then, following innate immune activation, guiding these activated cells to the draining lymph node to initiate and imprint an adaptive immune response. In this review, we will highlight recent advances in understanding how chemokine function regulates the movement and positioning of innate immune cells at homeostasis and in response to acute inflammation, and then we will review how chemokine-mediated innate immune cell trafficking plays an essential role in linking the innate and adaptive immune responses. hemokines are chemotactic cytokines that with emphasis placed on its role in the innate Ccontrol cell migration and cell positioning immune system. throughout development, homeostasis, and in- flammation. The immune system, which is de- pendent on the coordinated migration of cells, CHEMOKINES AND CHEMOKINE RECEPTORS is particularly dependent on chemokines for its function.
    [Show full text]
  • Chloride Channels Regulate Differentiation and Barrier Functions
    RESEARCH ARTICLE Chloride channels regulate differentiation and barrier functions of the mammalian airway Mu He1†*, Bing Wu2†, Wenlei Ye1, Daniel D Le2, Adriane W Sinclair3,4, Valeria Padovano5, Yuzhang Chen6, Ke-Xin Li1, Rene Sit2, Michelle Tan2, Michael J Caplan5, Norma Neff2, Yuh Nung Jan1,7,8, Spyros Darmanis2*, Lily Yeh Jan1,7,8* 1Department of Physiology, University of California, San Francisco, San Francisco, United States; 2Chan Zuckerberg Biohub, San Francisco, United States; 3Department of Urology, University of California, San Francisco, San Francisco, United States; 4Division of Pediatric Urology, University of California, San Francisco, Benioff Children’s Hospital, San Francisco, United States; 5Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Heaven, United States; 6Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, United States; 7Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States; 8Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States *For correspondence: Abstract The conducting airway forms a protective mucosal barrier and is the primary target of [email protected] (MH); [email protected] airway disorders. The molecular events required for the formation and function of the airway (SD); mucosal barrier, as well as the mechanisms by which barrier dysfunction leads to early onset airway [email protected] (LYJ) diseases,
    [Show full text]